INMUNE BIO INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
INMUNE BIO INC. (INMB) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 5.42 thousand shares for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-01.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2023-11-01
- INMUNE BIO INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2023-09-30 was 0.00 shares.
- INMUNE BIO INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2023-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- INMUNE BIO INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2023-03-31 was 5.42K shares, a 79.69% decline year-over-year.
- INMUNE BIO INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2022-12-31 was 9.58K shares.
- INMUNE BIO INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2022 was 74.58K shares.
- INMUNE BIO INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2018 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | 0.00 shares derived: sum of 2 quarters · filed 2023-11-01 | 5.42K shares 10-Q · filed 2023-11-01 | 15.00K shares derived: sum of 4 quarters · filed 2023-11-01 |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | 5.42K shares 10-Q · filed 2023-08-07 | 15.00K shares derived: sum of 3 quarters · filed 2023-08-07 | 15.00K shares derived: sum of 4 quarters · filed 2023-08-07 |
| 2023-03-31 | 5.42K shares 10-Q · filed 2023-05-03 | 15.00K shares derived: sum of 2 quarters · filed 2023-05-03 | 15.00K shares derived: sum of 3 quarters · filed 2023-05-03 | 53.33K shares derived: sum of 4 quarters · filed 2023-05-03 |
| 2022-12-31 | 9.58K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | 9.58K shares derived: sum of 2 quarters · filed 2023-03-02 | 47.92K shares derived: sum of 3 quarters · filed 2023-03-02 | 74.58K shares 10-K · filed 2023-03-02 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | 38.33K shares derived: sum of 2 quarters · filed 2022-11-02 | 65.00K shares 10-Q · filed 2022-11-02 | |
| 2022-06-30 | 38.33K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | 65.00K shares 10-Q · filed 2022-08-03 | ||
| 2022-03-31 | 26.67K shares 10-Q · filed 2022-05-05 | |||
| 2019-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | 0.00 shares 10-Q · filed 2019-08-09 | ||
| 2019-03-31 | 0.00 shares 10-Q · filed 2019-05-15 | |||
| 2018-12-31 | 0.00 shares 10-K · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |